title: SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016).
abstract: Chemotherapy-induced nausea and vomiting is one of the most worrisome adverse effects of chemotherapy for cancer patients. It can cause severe discomfort and affect the quality of life. In recent years, the incorporation of new drugs has increased the efficacy of antiemetic treatments in the control of emesis associated with chemotherapy. This guideline, in which we give some treatment recommendations with level of evidence and grade of recommendation, provides an update of the previously published guideline of the Spanish Society of Medical Oncology and represents our continued commitment to improving supportive care in cancer patients.
authors.affiliation: Servicio de Oncología Médica, Consorcio Hospital Provincial de Castellón, Avda. Dr. Clará, 19, 12002, Castellón de la Plana, Castellón, Spain. ramon.delaspenas@hospital2000.net.
authors.forename: R
authors.initials: R
authors.lastname: de Las Peñas
authors.affiliation: Servicio de Oncología Médica, Hospital General Universitario de Valencia, Valencia, Spain.
authors.forename: A
authors.initials: A
authors.lastname: Blasco
authors.affiliation: Servicio de Oncología Médica, Hospital Universitario la Paz de Madrid, Madrid, Spain.
authors.forename: J
authors.initials: J
authors.lastname: De Castro
authors.affiliation: Servicio de Oncología Médica, Hospital General Universitario Gregorio Marañón de Madrid, Madrid, Spain.
authors.forename: Y
authors.initials: Y
authors.lastname: Escobar
authors.affiliation: Servicio de Oncología Médica, Complexo Hospitalario Universitario A Coruña (Hospital Juan Canalejo), A Coruña, Spain.
authors.forename: R
authors.initials: R
authors.lastname: García-Campelo
authors.affiliation: Servicio de Oncología Médica, Clínica Universitaria de Navarra, Pamplona, Spain.
authors.forename: A
authors.initials: A
authors.lastname: Gúrpide
authors.affiliation: Servicio de Oncología Médica, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
authors.forename: R
authors.initials: R
authors.lastname: Lopez-Lopez
authors.affiliation: Servicio de Oncología Médica, Hospital de la Santa Creu I Sant Pau de Barcelona, Barcelona, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Majem
authors.affiliation: Servicio de Oncología Médica, Hospital Universitario de Salamanca, Salamanca, Spain.
authors.forename: C A
authors.initials: CA
authors.lastname: Rodríguez
authors.affiliation: Servicio de Oncología Médica, Complejo Hospitalario Regional Virgen Macarena de Sevilla, Sevilla, Spain.
authors.forename: J A
authors.initials: JA
authors.lastname: Virizuela
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D006801:Humans; D009325:Nausea / Q000139:chemically induced* / Q000517:prevention & control*; D009369:Neoplasms / Q000188:drug therapy; D017410:Practice Guidelines as Topic; D011788:Quality of Life; D013030:Spain; D014839:Vomiting / Q000139:chemically induced* / Q000517:prevention & control*
chemical_list: D000970:Antineoplastic Agents
keywords: Antiemetic drugs; Chemotherapy-induced emesis; Prophylaxis of emesis; SEOM guidelines of antiemetic drugs